• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病因子的硫酸化

Sulfation of von Willebrand factor.

作者信息

Carew J A, Browning P J, Lynch D C

机构信息

Department of Medicine, Harvard Medical School, Boston, MA.

出版信息

Blood. 1990 Dec 15;76(12):2530-9.

PMID:2265247
Abstract

von Willebrand factor (vWF) is a multimeric adhesive glycoprotein essential for normal hemostasis. We have discovered that cultured human umbilical vein endothelial cells incorporate inorganic sulfate into vWF. Following immunoisolation and analysis by polyacrylamide or agarose gel electrophoresis, metabolically labeled vWF was found to have incorporated [35S]-sulfate into all secreted multimer species. The time course of incorporation shows that sulfation occurs late in the biosynthesis of vWF, near the point at which multimerization occurs. Quantitative analysis suggests the presence, on average, of one molecule of sulfate per mature vWF subunit. Virtually all the detectable sulfate is released from the mature vWF subunit by treatment with endoglycosidases that remove asparagine-linked carbohydrates. Sulfated carbohydrate was localized first to the N-terminal half of the mature subunit (amino acids 1 through 1,365) by partial proteolytic digestion with protease V8; and subsequently to a smaller fragment within this region (amino acids 273 through 511) by sequential digestions with protease V8 and trypsin. Thus, the carbohydrate at asparagine 384 and/or 468 appears to be the site of sulfate modification. Sodium chlorate, an inhibitor of adenosine triphosphate-sulfurylase, blocks sulfation of vWF without affecting either the ability of vWF to assemble into high molecular weight multimers or the ability of vWF multimers to enter Weible-Palade bodies. The stability of vWF multimers in the presence of an endothelial cell monolayer also was unaffected by the sulfation state. Additionally, we have found that the cleaved propeptide of vWF is sulfated on asparagine-linked carbohydrate.

摘要

血管性血友病因子(vWF)是一种多聚体黏附糖蛋白,对正常止血至关重要。我们发现,培养的人脐静脉内皮细胞会将无机硫酸盐掺入vWF中。经过免疫分离并用聚丙烯酰胺或琼脂糖凝胶电泳分析后,发现经代谢标记的vWF已将[35S] - 硫酸盐掺入所有分泌的多聚体种类中。掺入的时间进程表明,硫酸化发生在vWF生物合成的后期,接近多聚化发生的时间点。定量分析表明,每个成熟的vWF亚基平均存在一个硫酸盐分子。实际上,所有可检测到的硫酸盐通过用去除天冬酰胺连接碳水化合物的内切糖苷酶处理从成熟的vWF亚基中释放出来。首先通过用蛋白酶V8进行部分蛋白水解消化,将硫酸化的碳水化合物定位到成熟亚基的N端一半(氨基酸1至1365);随后通过用蛋白酶V8和胰蛋白酶依次消化,将其定位到该区域内的一个较小片段(氨基酸273至511)。因此,天冬酰胺384和/或468处的碳水化合物似乎是硫酸盐修饰的位点。氯酸钠是三磷酸腺苷 - 硫酰化酶的抑制剂,它会阻断vWF的硫酸化,而不影响vWF组装成高分子量多聚体的能力或vWF多聚体进入魏贝尔 - 帕拉德小体的能力。在内皮细胞单层存在的情况下,vWF多聚体的稳定性也不受硫酸化状态的影响。此外,我们发现vWF的裂解前肽在天冬酰胺连接的碳水化合物上发生了硫酸化。

相似文献

1
Sulfation of von Willebrand factor.血管性血友病因子的硫酸化
Blood. 1990 Dec 15;76(12):2530-9.
2
von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.血管性血友病因子的蛋白水解加工和多聚化先于魏尔-帕拉德小体的形成。
Blood. 1994 Jun 15;83(12):3536-44.
3
An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.内皮细胞合成的血管性血友病因子中微小多聚体种类的解释。
J Clin Invest. 1986 Jun;77(6):2048-51. doi: 10.1172/JCI112535.
4
Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin.血管性血友病因子与交联或非交联纤维蛋白结合的多聚体大小依赖性
Blood. 1990 Apr 1;75(7):1460-5.
5
Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor.培养的内皮细胞的内皮下基质含有完全加工的高分子量血管性血友病因子。
J Lab Clin Med. 1989 Mar;113(3):372-8.
6
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
7
Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.人血管性血友病因子的亚结构。经V8蛋白酶水解及两个功能结构域的特性分析
J Biol Chem. 1986 Nov 25;261(33):15679-89.
8
Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage.唾液酸通过防止氨基末端蛋白水解切割,从而防止大的血管性血友病因子多聚体丢失。
Blood. 1988 Nov;72(5):1790-6.
9
Clearance of normal and type 2A von Willebrand factor in the rat.大鼠体内正常和2A型血管性血友病因子的清除
Blood. 1996 Sep 1;88(5):1692-9.
10
Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.纤溶酶对血管性血友病因子多聚体的影响。体外降解及体内释放刺激。
J Clin Invest. 1985 Jul;76(1):261-70. doi: 10.1172/JCI111956.

引用本文的文献

1
The Manifold Cellular Functions of von Willebrand Factor.血管性血友病因子的多功能性。
Cells. 2021 Sep 8;10(9):2351. doi: 10.3390/cells10092351.
2
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.检测血管性血友病因子(VWF)前肽以识别血管性血友病1型且VWF生存期缩短的患者。
Blood. 2006 Nov 15;108(10):3344-51. doi: 10.1182/blood-2006-04-015065. Epub 2006 Jul 11.
3
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
在血管性血友病(VWD)内皮细胞中重新建立依赖血管性血友病因子(VWF)的魏尔-帕拉德小体。
Blood. 2005 Jan 1;105(1):145-52. doi: 10.1182/blood-2004-02-0464. Epub 2004 Aug 26.
4
Recombinant von Willebrand factor: potential therapeutic use.重组血管性血友病因子:潜在的治疗用途。
J Thromb Thrombolysis. 1999 Oct;8(3):197-205. doi: 10.1023/a:1008906103637.
5
Molecular markers near the mouse brachymorphic (bm) gene, which affects connective tissues and bleeding time.靠近小鼠短尾(bm)基因的分子标记,该基因影响结缔组织和出血时间。
Mamm Genome. 1996 Feb;7(2):98-102. doi: 10.1007/s003359900027.
6
O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.重组血管性血友病因子的O-连接碳水化合物影响瑞斯托霉素诱导的与血小板糖蛋白1b的结合。
J Clin Invest. 1992 Dec;90(6):2258-67. doi: 10.1172/JCI116112.